Gatorade recall affects drinks sold in New York and New Jersey
Multiple outlets report on a nationwide recall affecting millions of bottles of Gatorade products distributed across dozens of states.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
Recent reporting outlines a significant product recall impacting thousands of cases and millions of bottles of Gatorade across the United States. According to coverage from PIX11, the Food and Drug Administration announced the action involving thousands of cases of the popular sports drink. EatingWell further details that over 1.8 million individual bottles are currently affected by the nationwide recall effort. Simultaneously, WSTM reports that parent company PepsiCo has initiated a recall covering over 120,000 cases spanning 37 states, highlighting the broad geographic scope of the distribution impact. Coverage emphasizes conflicting figures regarding the exact scale of the recall, with specific reports highlighting thousands of cases, over 1.8 million individual bottles, and separate totals of over 120,000 cases distributed across 37 states.
Outlets covering these developments include PIX11, EatingWell, and WSTM. The reporting notes that the Food and Drug Administration is involved alongside parent company PepsiCo, though current coverage does not yet specify the exact underlying reason for the safety action or detailed lot numbers for consumers to check. Context provided by the reporting frames this as a major logistics and consumer safety event involving one of the nation's most recognizable beverage brands. Because Gatorade is widely distributed through retail supply chains across dozens of states, a nationwide recall of this magnitude requires coordinated communication between federal regulators, the manufacturer, and retail partners. The existing coverage establishes the involvement of PepsiCo and the Food and Drug Administration, but leaves open many logistical details regarding how the affected products will be collected, returned, or safely disposed of by purchasers.
Future coverage will likely monitor updates from the Food and Drug Administration and PepsiCo regarding the specific lot numbers affected, the exact product varieties involved, and instructions for consumers who have already purchased the recalled drinks. Observers will also track whether the recall expands beyond the currently reported 37 states or if additional volume figures are released as the regulatory process unfolds. Readers should look to official regulatory channels and manufacturer announcements for the definitive guidance on safety steps, refunds, and return procedures as new information becomes available.
Synthesized by PULSE from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 40d ago.
Quick answers
Who is recalling the Gatorade products?
Coverage from WSTM identifies PepsiCo as the company issuing the recall, with the Food and Drug Administration also noted by PIX11.
How many products are affected?
EatingWell reports over 1.8 million bottles, while WSTM reports over 120,000 cases and PIX11 notes thousands of cases.
How many states are affected?
According to WSTM, the recall impacts products across 37 states.
Coverage (5)
- Thousands of cases of Gatorade recalled nationwide: FDA PIX11 · 41d ago
- Over 1.8 Million Bottles of Gatorade Are Being Recalled Nationwide EatingWell · 41d ago
- PepsiCo recalls over 120,000 cases of Gatorade in 37 states WSTM · 41d ago
- PepsiCo recalls 122K cases of Gatorade Lemon Lime due to undeclared yellow dyes Top Class Actions · 41d ago
- Gatorade recall affects New York. See which products are included Democrat and Chronicle · 41d ago
Topics
Related trends
The Children's Place plans store closures after filing for bankruptcy, sets gift card deadline
The Children's Place filed for Chapter 11 bankruptcy and announced nationwide store closures with a gift card redemption deadline.
Novo says Wegovy injection lowers BMI and obesity rates in children in trial
Novo Nordisk announces trial data showing Wegovy injection reduces BMI and obesity rates in children as young as six, expanding weight-loss drug use to elementary-age patients.
A Classic Car Show From Paris Aims to Turn Heads in Manhattan
The renowned Paris classic car show Retromobile makes its official New York debut in Manhattan, featuring Larry Warsh’s art cars.
The GLP-1 boom has a dark side
The FDA orders eye risk warnings on GLP-1 medications like Ozempic and Zepbound, prompting expert guidance.
Have the sniffles? See if respiratory illnesses are rising near you
The 2026 U.S. flu season has arrived more than two months early, with seven states already reporting high activity and New York logging over 12,000 cases in a single week.
FDA rejects Summit’s ivonescimab, derailing US arrival of much-hyped PD-1xVEGF class
The United States Food and Drug Administration has rejected Summit Therapeutics and Akeso's lung cancer drug ivonescimab.